Novus Biologicals™ TAB1 Antibody Blocking Peptide

Catalog No.	Quantity
NBP176595E	0.05 mg

Catalog No. NBP176595E Supplier Novus Biologicals™ Supplier No. NBP176595PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 13 amino acids near the center of human TAB1. Source: Synthetic (Accession #: NP_006107) The TAB1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 10454
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-76595. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: MAP3K7IP13'-Tab1, MGC57664, mitogen-activated protein kinase kinase kinase 7 interacting protein 1, Mitogen-activated protein kinase kinase kinase 7-interacting protein 1, TAK1-binding protein 1, TGF-beta activated kinase 1/MAP3K7 binding protein 1, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1, TGF-beta-activated kinase 1-binding protein 1, transforming growth factor beta-activated kinase-binding protein 1
• Gene Symbol: TAB1
• Product Type: TAB1
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 13 amino acids near the center of human TAB1